ClearRead CT - Vessel Suppress

Riverain Technologies

Riverain’s ClearRead CT Vessel Suppress is powered by machine learning and advanced modeling and suppresses vascular structures. The vessel suppression algorithm works with contrast and non-contrast scans, and operates on slices with section thickness up to 5mm.

Information source: Vendor
Last updated: April 19, 2022

General Information

General
Product name	ClearRead CT - Vessel Suppress
Company	Riverain Technologies
Subspeciality	Chest
Modality	CT
Disease targeted	Lung cancer
Key-features	Vessel suppression
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps)

Technical Specifications

Data characteristics
Population	Adult population, not cleared for pediatric use.
Input	Contrast and non-contrast chest CT, slices thickness up to 5mm
Input format	DICOM
Output	Vessels suppressed CT chest series registered to original series for synchronized scrolling/concurrent reading
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS)
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis	Configured per site settings to be automated based on conditions
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDR
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)	ClearRead CT is comprised of computer assisted reading tools designed to aid the radiologist in the detection of pulmonary nodules during review of CT examinations of the chest on an asymptomatic population. The ClearRead CT requires both lungs be in the field of view. ClearRead CT provides adjunctive information and is not intended to be used without the original CT series.

Market

Market presence
On market since	11-2015
Distribution channels	Nuance PIN, Sectra Amplifier Store, Aidoc aiOS, GE Healthcare Edison platform, Eureka Clinical AI Platform, Philips AI Marketplace, Agfa PACS, Blackford Marketplace, Fuji PACS, Change HC PACS, Calantic
Countries present (clinical, non-research use)	Over 10
Paying clinical customers (institutes)	Over 100
Research/test users (institutes)
Pricing
Pricing model	Subscription, One-time license fee
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance	Artificial intelligence-based vessel suppression for detection of sub-solid nodules in lung cancer screening computed tomography (read) Vessel suppressed chest Computed Tomography for semi-automated volumetric measurements of solid pulmonary nodules (read) JOURNAL CLUB: Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function (read) All papers are available here
Non-peer reviewed papers on performance	Case Studies
Other relevant papers